Get access

Systemic administration of fluorogold for anatomical pre-labeling of autonomic and motor neurons in the rat spinal cord compromises urodynamic recordings in acute but not long-term studies

Authors

  • Huiyi H. Chang,

    1. Department of Anesthesiology & Perioperative Care, University of California at Irvine School of Medicine, Irvine, California
    2. Reeve-Irvine Research Center, University of California at Irvine School of Medicine, Irvine, California
    Search for more papers by this author
  • Leif A. Havton

    Corresponding author
    1. Department of Anesthesiology & Perioperative Care, University of California at Irvine School of Medicine, Irvine, California
    2. Reeve-Irvine Research Center, University of California at Irvine School of Medicine, Irvine, California
    3. Department of Neurology, University of California at Irvine School of Medicine, Irvine, California
    • Reeve-Irvine Research Center, Department of Anesthesiology & Perioperative Care, University of California at Irvine School of Medicine, Gillespie Neuroscience Research Facility, Rm 2121, 837 Health Science Road, Irvine, CA 92697.
    Search for more papers by this author

  • Lori Birder led the review process.

  • Conflict of interest: none.

Abstract

Aims

The use of anatomical tracer injections into peripheral tissues for retrograde labeling of spinal cord neurons may compromise physiological experiments in combined functional and morphological studies.

Methods

We investigated whether a systemic injection of a retrogradely transported tracer, fluorogold (FG), may provide an alternative to direct injections into end organs for combined anatomical and physiological studies of the lower urinary tract. Urodynamic studies including cystometrogram recordings and external urethral sphincter electromyography were used as functional outcome measures.

Results

Pre-labeling of spinal cord neurons by intraperitoneal (i.p.) administration of FG resulted in a transient decrease in voiding efficiency, increase in resting pressure as well as increase in bladder size and weight at 5–7 days after the tracer administration. In contrast, there were no urodynamic or end-organ effects detected at 6–8 weeks after the i.p. injection of FG.

Conclusions

We suggest that pre-labeling of spinal autonomic and motor neurons using i.p. administration of FG may be a useful tool when combining anatomical and functional outcome measures in long-term but not acute studies. Neurourol. Urodynam. 31:162–167, 2012. © 2011 Wiley Periodicals, Inc.

Get access to the full text of this article

Ancillary